Jason Litten - 02 Jan 2026 Form 4 Insider Report for GENELUX Corp (GNLX)

Role: Chief Medical Officer
Signature: /s/ Eric Groen, Attorney-in-Fact
Issuer symbol: GNLX
Transactions as of: 02 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 07 Jan 2026, 17:32:02 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Litten Jason	Chief Medical Officer	C/O GENELUX CORPORATION, 2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE	/s/ Eric Groen, Attorney-in-Fact	07 Jan 2026	0001909400

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GNLX	Stock Option (Right to Buy)	Award	$0	+275,000		$0.000000	275,000	02 Jan 2026	Common Stock	275,000	$4.55	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option will vest 25% on the first anniversary of the grant date, and the remaining shares will vest in 36 equal monthly installments thereafter.